← Back to Search

Robotic Exoskeleton

Adaptive Hip Exoskeleton for Stroke Rehabilitation

N/A
Waitlist Available
Led By Aaron Young, Ph.D.
Research Sponsored by Georgia Institute of Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial will test new algorithms for robotic exoskeletons by having individuals who have previously had a stroke walk while wearing the device. The goal is to compare the performance of the advanced algorithm with not using the device to determine the clinical benefit.

Who is the study for?
This trial is for individuals aged 18-85 who've had a stroke at least 6 months ago, can walk a bit without support, and have basic mental and physical capabilities to participate in the study. Those with severe neurological conditions other than stroke, recent concussions, certain heart diseases, or major sensory impairments cannot join.Check my eligibility
What is being tested?
The trial tests an advanced robotic hip exoskeleton designed to enhance walking post-stroke. Participants will use this device on a treadmill while researchers compare their gait performance with and without the exoskeleton's new algorithms.See study design
What are the potential side effects?
Potential side effects may include discomfort from wearing the device, skin irritation where it attaches to the body, muscle fatigue due to exercise or unusual movements during testing.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Self-Selected Walking Speed

Trial Design

1Treatment groups
Experimental Treatment
Group I: Powered Hip Exoskeleton for Stroke AssistanceExperimental Treatment1 Intervention
This study will be conducted on a sample population of stroke subjects (single arm). Each subject will test with each condition of the exoskeleton (repeated measures).

Find a Location

Who is running the clinical trial?

Georgia Institute of TechnologyLead Sponsor
49 Previous Clinical Trials
5,534 Total Patients Enrolled
5 Trials studying Stroke
101 Patients Enrolled for Stroke
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,978 Previous Clinical Trials
2,680,341 Total Patients Enrolled
79 Trials studying Stroke
5,375 Patients Enrolled for Stroke
Aaron Young, Ph.D.Principal InvestigatorGeorgia Institute of Technology
3 Previous Clinical Trials
30 Total Patients Enrolled
1 Trials studying Stroke
10 Patients Enrolled for Stroke

Media Library

Robotic Hip Exoskeleton (Robotic Exoskeleton) Clinical Trial Eligibility Overview. Trial Name: NCT05536739 — N/A
Stroke Research Study Groups: Powered Hip Exoskeleton for Stroke Assistance
Stroke Clinical Trial 2023: Robotic Hip Exoskeleton Highlights & Side Effects. Trial Name: NCT05536739 — N/A
Robotic Hip Exoskeleton (Robotic Exoskeleton) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05536739 — N/A
~8 spots leftby Apr 2027